Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma

Elisabete Teixeira(Universidade do Porto), Paula Soares(Universidade do Porto)

International Journal of Molecular Sciences

January 26, 2024

10.3390/ijms25031522

Cited by 3

Related Papers

The mTOR Signalling Pathway in Human Cancer

|International Journal of Molecular Sciences|2012|831

AZD1480 Blocks Growth and Tumorigenesis of RET- Activated Thyroid Cancer Cell Lines

|PLoS ONE|2012|24

TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes

|Scientific Reports|2016|19

In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp

|Endocrine Related Cancer|2011|13